logo
Share SHARE
FONT-SIZE Plus   Neg

Statoil To Sell Stakes In Several Fields Offshore Norway To OMV For $2.65 Bln

Statoil ASA (STO) said Monday that it has signed an agreement to divest minority interests in several fields offshore Norway to Austrian oil and gas company OMV for $2.65 billion in cash.

Statoil said it will divest minority interests in the Gullfaks and Gudrun fields offshore Norway and exit the non-core, non-operated Schiehallion and Rosebank fields, West of Shetlands.

In addition, the transaction with OMV includes a contingent payment and involves a partnership between the two companies. Statoil noted that it reduces its ownership share in Gullfaks to 51 % from 70 % and to 51 % from 75 % in Gudrun, and retains its operatorships on both fields.

Statoil said it expects to recognize a gain from the transaction estimated to be between $1.3 billion - $1.5 billion, to be adjusted for activity between the effective date 1 January 2013 and the closing date.

The company noted that the transaction will enable it to redeploy around $7 billion of capital expenditure, around $5.5 billion of which is pre-2020, excluding potential investments in the recent Shetland/Lista discovery at Gullfaks.

OMV is an established company on both the Norwegian or NCS and the UK (UKCS) continental shelves.

Statoil and OMV enter into a partnership including potential cooperation on exploration opportunities across Norway, the UK and the Faroese Islands as well as the development of Enhanced Oil Recovery or EOR technologies.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Billionaire Warren Buffett's Berkshire Hathaway Inc. (BRK.A, BRK.B) Friday said its first-quarter profit rose from last year, as revenues increased. However, the company's operating profit dropped hurt by derivative losses and lower railroad revenues. Berkshire is a holding company with a number... Rare commodities are worth more than good is a Chinese adage. And more so when it is in the sought-after drug space. Rare and ultra-rare diseases, also called orphan and ultra-orphan diseases, as the names imply, affect very small numbers of patients. So why the clamor? Shares of steel giant ArcelorMittal were losing around 4 percent in the early morning trading in Amsterdam after the company reported sharp decline in first-quarter EBITDA, a key earnings metric, as sales were weak with lower prices and production. Net loss, however, narrowed from last year. The company also confirmed its forecast for annual EBITDA, which is lower than last year.
comments powered by Disqus
Follow RTT